MYND Life Sciences Inc (MYND)

[namah sivaya]

Forbes article on telepsychiatry....

https://www.forbes.com/sites/shourjyasanyal/2019/01/28/how-is-telepsychiatry-revolutionizing-care/#10c2e0af124d

[namah sivaya]

Telemedicine usage increasing at rapid rates to save $

Teladoc reportedly conducted some 1,500 telehealth visits in the state in 2018, saving its employer customers roughly $700,000 in healthcare costs.

https://mhealthintelligence.com/news/nd-lawmakers-amend-bill-to-support-store-and-forward-telemedicine

[namah sivaya]

How Telemedicine Can Revolutionize The Healthcare Market....

https://www.acsh.org/news/2019/01/30/how-telemedicine-can-revolutionize-healthcare-market-13769

[namah sivaya]

MYND recommended at Small Cap Stocks Today

talk of MYND at 7:27 mark....

https://soundcloud.com/smallcapstockstoday

[BoilerRoom]

Weeeeeeeeeeeeee! Lol

[namah sivaya]

MYND's 6% stake is worth $13.5M, or about double current market value, based on $225M valuation for Emmaus. which is probably low since this was more than a year before the eventual approval...

[namah sivaya]

in 2017 Emmaus' rejected $225M deal!!

here is an article about the company MYND did reverse merger with....

https://endpts.com/mystery-biotech-emmaus-grabs-a-big-win-as-fda-experts-endorse-sickle-cell-drug-right-after-scrapping-a-225m-deal/

[namah sivaya]

and here is a recent article explaining the details of the merger with Emmaus' Life Sciences....

https://finance.yahoo.com/news/mynd-analytics-emmaus-life-sciences-123000204.html

[namah sivaya]

here is a great news report NY/CBS aired recently about MYND PEER device and how it works...

https://newyork.cbslocal.com/2018/11/01/mynd-analytics-test-for-depression/

[namah sivaya]

Insiders own more than 35% of MYND!

in 2018 insiders on two occasions bought the ENTIRETY of 2 private placements and at higher than current prices!
in April 2018 insiders bought 1,000,000 shares @$2
in September insiders bought 460,000 shares $1.85....

we know why, the Emmaus' Life Sciences merger announced last week is HUGE!
they have a recently FDA approved drug Endari. Endari is a drug for the complications associated with Sickle Cell disease. A disease that affects millions worldwide. The company has said the addressable market is more than $3B annually!

in this merger MYND ends up with 6% of Emmaus' which should be worth at least $3/share and maybe as high as $5/share.

And then MYND is spinning off the original telemedicine and AI/predictive analytics company.


this is my favorite stock for 2019!

[PennyStock Alert]

Doubt we see sub $1

[PennyStock Alert]

Very low float

[PennyStock Alert]

* * $MYND Video Chart 10-26-18 * *

Link to Video - click here to watch the technical chart video

[PennyStock Alert]

Looks good here for an entry

[newlevel87]

Wat it do money

[tw0122]

Out of here at $1.05 volume slowed drastically

[tw0122]

Bought the 99 Cent special. 1/4th position only

[Whale Gunna]

Huuuuge run in the works here, shorts are starting to get squeezed leading up the the mega PR campaign

[EL CHAPO]

After hours up

[EL CHAPO]

Loading up here. Look for $2+ tomorrow. Nasdaq special. You’re welcome.

[halpern6]

agreed....looking good here..eom

[ClayTrader]

* * $MYND Video Chart 10-26-18 * *

Link to Video - click here to watch the technical chart video

[aristotelisonassis]

could see $3-4. Very low float here.

[aristotelisonassis]

holding for the next week.

[aristotelisonassis]

Long!

[dave7933]

Nice rise today in a nasty market!